P436: TARGETED DELIVERY OF T22-PE24-H6 TO CXCR4 POSITIVE CELLS FOR ACUTE MYELOID LEUKEMIA TREATMENT

• Y. Núñez Amela,
• A. Garcia-León,
• A. Falgàs,
• N. Serna,
• L. Sánchez-García,
• A. Garrido,
• J. Sierra,
• A. Gallardo,
• U. Unzueta,
• E. Vázquez,
• A. Villaverde,
• R. Mangues,
• I. Casanova

Affiliations

Y. Núñez Amela

1 Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona

A. Garcia-León

1 Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona

A. Falgàs

1 Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona

N. Serna

3 CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid

L. Sánchez-García

3 CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid

A. Garrido

2 Josep Carreras Leukaemia Research Institute (IJC), Badalona

J. Sierra

2 Josep Carreras Leukaemia Research Institute (IJC), Badalona

A. Gallardo

1 Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona

U. Unzueta

1 Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona

E. Vázquez

3 CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid

A. Villaverde

3 CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid

R. Mangues

1 Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona

I. Casanova

1 Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona